ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[FASLG, PRL, HHEX, EMILIN1, HOXA5, CCR2, DCN, HGS, CX3CR1, THBS1, TGFB2, PLK2, TIE1, CXCL10, TEK, PF4]
GO:2000481;positive regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1426.5997261217476;8.16763571524637;0.0477470089768964;0.8658135829017477;[ADRB2, SIRT1]
GO:2000483;negative regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;7.8311634786251565;0.02523477878196853;0.8157270763441555;[ANXA1, PTPN22, TLR6]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, ACTN4, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, CCL19, TNFSF14, TNFRSF10B, NLRP12, IL18R1]
GO:1900134;negative regulation of renin secretion into blood stream;9.0;1.0;0.896240625180289;9.628524252492122;591.2347477709419;9.777073627680469;0.01978809493116578;0.896240625180289;[F2R]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[PLXND1, CXCL13, CDH5, C3AR1, PROK2, CYP1B1, HOXA5, GHSR, SFRP2, HGS, ADAM12, AGTR1, EPHA2, C5AR1, PLCG1, TGFB2, JUP, PLK2, TNFSF12, CXCL10, IL6, ID1, NRP1, TNFAIP3, FASLG, PRL, HHEX, CTSH, EMILIN1, CCR2, ANXA1, ANXA3, GAB1, SIRT1, DCN, CEACAM1, IL1B, CHI3L1, ENG, CX3CR1, PTGS2, DLL1, THBS1, GPNMB, CXCR2, TIE1, LRG1, TEK, PF4]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, CD40LG, MDFIC, PKN1]
GO:1900138;negative regulation of phospholipase A2 activity;8.0;1.0;0.875;9.628524252492122;83.36451349999537;8.67846133901236;0.002790135243653613;0.8188169164668168;[ANXA1]
GO:0021795;cerebral cortex cell migration;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;22.93064785239865;6.641579411751319;7.67468147376534E-4;0.6905700452391912;[CX3CR1, NRP1]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, CDH5, C3AR1, CTSH, CYP1B1, GHSR, ANXA1, ANXA3, GAB1, SIRT1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, PTGS2, DLL1, THBS1, CXCR2, PLCG1, JUP, PLK2, TNFSF12, LRG1, TEK]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, TNF, SOX4, GHSR, IFNG, IL1B, CFTR, BLK, KCNA5, DPP4, CNR1, CCL5]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, EGF, MAPK14, CD40LG, CSPG4, PKN1]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[LRRK2, EGF, F2R, ADAM9]
GO:0048247;lymphocyte chemotaxis;7.0;0.7671156992804218;0.7344772148974115;9.303101852057495;94.37808318069546;5.926926025970411;0.003158749509297446;0.6540226378555745;[CCL13, CXCL9, CCL23, CCL21, CCL20, DEFA1, CXCL13, CXCL16, CXCL10, CXCL11, CCL8, CCL7, CCL5, CCL4, CCL2, XCL1, CCL1, CCL19, CCL18, CCR2]
GO:0048246;macrophage chemotaxis;8.0;1.0;0.875;9.628524252492122;95.91852822164125;7.212124270218933;0.0032103068185073717;0.7438283705770736;[CX3CR1, LGALS3, EDNRB, NUP85, CCL5, CCL2, AZU1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, JUN, JAG1, JUP, COL1A1, FOS, SIRT1, MMP12, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, BLM, FOXO1, NFKB1, CXCL10, CIITA, HHEX, PPP1R12A, E2F5, E2F7, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, BRCA2, CD3D, RGMA, IL1B, YAP1, IL17A, CD86, CD80, CCNE1, HMGA1, INHBA, IL6, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, NFE2, FZD5, TGFB1I1, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, CYR61, LBH, EMILIN1, RFC1, CHUK, SMARCD3, CEBPE, ABLIM3, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, NHLH2, BCL11B, IFNA2, PRL, RHOG, MDFIC, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, MEIS2, MEIS1, RBMX]
GO:0045651;positive regulation of macrophage differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;7.212124270218933;0.0281402778535103;0.7650689957573628;[PF4]
GO:0048245;eosinophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;6.7325511899570465;0.004360933283440787;0.740543606130341;[LGALS3, CCL13, CCL23, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0010536;positive regulation of activation of Janus kinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;2488.7782735422925;7.8311634786251565;0.08329716906043155;0.8329150168128974;[GH1, CCL5, IL6R]
GO:2000110;negative regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.26138950429646;7.9853141584524145;0.008576838086431384;0.8046099625986299;[GHSR, CCL5, CCR5]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ITGB3, HMGB2, TNFAIP3, LAMC1, CDH3, AKT1, GHSR, ARG1, SIRT1, PAX2, MMP12, AGTR1, C5AR1, TGFA, IQGAP3, CCL5, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:0070723;response to cholesterol;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;80.91680144162417;6.686031174322154;0.002708212523857764;0.665044257777226;[ABCA1, OSBPL7, TGFB1, INHBA, CCR5]
GO:0030260;entry into host cell;6.0;0.7369933605727446;0.6916169928765168;8.68406264365127;26.98811751292015;5.212725436212633;9.032680054285688E-4;0.5896993338145817;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, CDH1, ANPEP, CLEC5A, ITGB6, CCR5, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, CXCR4, DPP4, NCAM1, GPR15, CD4]
GO:1904504;positive regulation of lipophagy;9.0;1.0;0.896240625180289;9.628524252492122;315.93368011590877;8.16763571524637;0.0105740159516271;0.8139338954918922;[ADRB2]
GO:0045653;negative regulation of megakaryocyte differentiation;8.0;1.0;0.875;9.628524252492122;350.11976986482637;8.16763571524637;0.011718193610040062;0.7926932703116032;[PF4]
GO:0043117;positive regulation of vascular permeability;6.0;1.0;0.8231203125901445;9.628524252492122;22.58320658440663;7.474488534686424;7.558396008136816E-4;0.7053660038532718;[TGFB1, CXCR2]
GO:0002920;regulation of humoral immune response;5.0;0.5916390046238794;0.58606051417286;8.201407896851975;25.624977988756285;4.925043363760852;8.576449523007288E-4;0.5421079585215889;[C1QA, PROS1, C5AR1, CXCL13, TNF, IGHG1, IGKC, CD19, IGLV1-44, C3AR1, CCR7, CR2, CR1, FCER2, PTPN6, FCGR2B, IGKV3-20]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, EPB41L5, CCR7, CD36, JUP, CCL21, CEACAM6, TEK]
GO:0002922;positive regulation of humoral immune response;6.0;0.6997970393407541;0.6730188322605215;9.0306872517365;108.8065326900253;7.069023426578259;0.0036416567296131998;0.6846304993685643;[FCER2, CCR7, FCGR2B, TNF]
GO:0030816;positive regulation of cAMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.526741558182179;1396.5025295312637;6.139487467954083;0.04673968289273128;0.7292146864874571;[CXCL10, LHCGR, CXCL9, CXCL11, RAMP1, TSHR, PF4]
GO:0010666;positive regulation of cardiac muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.5070754231924;7.474488534686424;0.005003867266781941;0.7974867031240476;[CXCR2]
GO:0031584;activation of phospholipase D activity;8.0;1.0;0.875;9.628524252492122;67.57805180902054;7.9853141584524145;0.0022617765777498177;0.7833693374183408;[CCL5]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[DSP, ANXA1, F13A1, THBS1, DCN, SPOCK3]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[F2R, TLR1, CD2, PYCARD, FFAR2, CD58, CD244, TLR2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, GAB1, VAV1, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK]
GO:0043922;negative regulation by host of viral transcription;11.0;1.0;0.9324289523296623;9.628524252492122;272.3838172918008;7.292166977892469;0.009116441235236167;0.8053507106995271;[JUN, CCL5, CCL4]
GO:1900272;negative regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;54.24497338163739;7.57984905034425;0.0018155304417768478;0.7838744581139225;[CX3CR1]
GO:0035025;positive regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;339.6245583269611;6.481236761676141;0.01136692832494487;0.7466917612613706;[PDGFRB, F2R, GPR18, F2RL3]
GO:0031340;positive regulation of vesicle fusion;7.0;0.8259837884571596;0.7639112594857803;9.392135474427892;149.60751655096118;7.697632086000634;0.005007228940937215;0.7445766281117727;[ANXA1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[GOLT1B, TNF, AKT1, TNFSF11, F2R, CARD11, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, FLNA, FYN, CCL19, CCL21, CARD9, CD4, LTBR]
GO:0046632;alpha-beta T cell differentiation;7.0;0.7140352122741334;0.7079369713942671;9.04870575723918;90.58502354652471;6.166155715036245;0.0030317992168737967;0.6662568552797195;[ITK, BLM, GATA3, NKX2-3, ANXA1, BCL11B, BMX, GPR18, IL18R1]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[ARG1, SLC11A1, DEFA1, CLEC7A, PF4]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, SERPINA1, PROS1, ITGB3, ITGA2B, F13A1, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, ANXA5, ACTN4, F5, PECAM1, TLN1, VCL, STXBP2, THBS1, PSAP, FLNA, LYN, TGFB2, TGFB1, EGF, LHFPL2, PPBP, CD9, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, MEF2C, MAP2K2, PAQR3, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, HBEGF, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[TGFB1, TSC2, TNF, PAX2, TMEM100, CCL5, IL1B, AKT1, CCL2, EPHA2]
GO:0046883;regulation of hormone secretion;7.0;0.5326392268888578;0.6172389787016295;7.769625480426438;67.7447061739125;4.2087291239193725;0.0022673543493635607;0.5661539683803571;[KCNG2, TNF, MYB, TNFSF11, SOX4, GHSR, AGTR1, CFTR, BLK, DPP4, INHBA, FFAR2, ANXA1, IFNG, IL1B, KCNA5, RETN, CNR1, CCL5]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, FPR1, GATA3, FLRT2, HLA-DQA1, HLA-DRB4, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, FOS, SIRT1, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IFNA14, IFNA16, IFNA10, TNFRSF11A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, FASLG, TNFSF13B, CHUK, TNFRSF1B, XCL1, CX3CR1, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, PPBP, SDC1, IFNA5, IFNA4, IFNA7, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, IRAK3, MMP9, DCN, IFNG, SAMHD1, NCAM1, CD4, LTBR]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, PHB2, SLC8A1, CTGF, F2R, CACNA2D3, CALCRL, CUL5, PSEN2, CACNA1F, CORO1A, CCR1, CAV1, BSPRY, PTPRC, ATP2A3, FASLG, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, CCL8, PLN, CCL5, FYN, CCL19, CCL21, RAMP1]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14, THBS1]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0048260;positive regulation of receptor-mediated endocytosis;8.0;0.811012628672052;0.780506314336026;9.34084218004034;175.1727623766804;5.8650506222523235;0.005862874711496551;0.6749389615747303;[FMR1, RAB21, NTF3, CCL19, SYK, CCL21, EGF, SELE, DNM2, SFRP4]
GO:0033634;positive regulation of cell-cell adhesion mediated by integrin;6.0;1.0;0.8231203125901445;9.628524252492122;97.9646140837123;8.390779266560578;0.003278787470953165;0.7522251544931926;[CCL5, CXCL13]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, TNF, IL1B, AKT1, FYN, PF4]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[EGR3, COL1A1, NR4A1, CCL5, CCL2]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[ADRB2, SORT1, VPS41]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[MEF2C, BCL6, CXCL13]
GO:0071385;cellular response to glucocorticoid stimulus;8.0;0.8436909121759173;0.7968454560879586;9.454170865347344;407.2980594846617;5.734022359845919;0.01363189950649617;0.6682381701418294;[ABCB4, FOXO1, TGFB1, ANXA1, ARG1]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, CSF3R, C5AR1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL1, S100A8, PF4]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, AKT1, MAPK14]
GO:0033625;positive regulation of integrin activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;140.3817219977405;8.16763571524637;0.004698449899916962;0.7686126355688037;[CXCL13]
GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1143.6879814690685;7.212124270218933;0.03827820748741112;0.8169486831672182;[EGF, PDGFC, ADRB2]
GO:0038116;chemokine (C-C motif) ligand 21 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0038115;chemokine (C-C motif) ligand 19 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[ANXA1]
GO:0030194;positive regulation of blood coagulation;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;205.4468638594546;6.518977089658987;0.006876121643202558;0.7083807915285978;[F2R, THBS1, PDPN, CD36, TLR4]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, CD24]
GO:0038112;interleukin-8-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;9.083926447120524;0.00101047745553359;0.8154717862087246;[CXCR1, CXCR2]
GO:0002282;microglial cell activation involved in immune response;7.0;1.0;0.8509193652572005;9.628524252492122;112.99588726958953;9.083926447120524;0.003781870657216873;0.8154717862087246;[CX3CR1]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, NCKAP1L, ELANE, LYN, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, OLR1, TIMP3, TIMP1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, FLNA, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, ATP8A1, PROS1, ITGA2B, HP, F13A1, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, LAT, ITGAM, ITGB3, FCAR, ALAD, FCGR3B, GM2A, DSP, CR1, VWF, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, CCL8, TTR, CCL5, FCGR2A, P2RX1, IMPDH2, VPS41, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CCR1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, TLR2, LILRA3, STX11, PAK1, CXCR1, CXCR2, CD58, CCT8, LHFPL2, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, TGFB2, TGFB1, SYT2, NR4A3, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, SYNGR3, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, THBS1, EGF, MAPK14, CD9, S100P, PTX3]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[LLGL2, EPHA2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ACAP1, PRTN3, ARHGAP15, ADAP2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, LRRK2, TAGAP, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[LAMB3, ADRB2, PTGS2, ALDH6A1, LRG1, PRDM16]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, E2F7]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, SKP2, ADRB2, NDFIP2, WFS1, CAV1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, CCL20, AZU1, SELE, LAT]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[MEF2C, TGFB1, ADRB2, SLC8A1, LTF]
GO:0035754;B cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;95.76437754181396;7.9853141584524145;0.003205147533980157;0.7833693374183408;[CXCL13]
GO:0090303;positive regulation of wound healing;7.0;0.7043150770688792;0.7030769037916401;8.753055515138222;62.345319237194666;5.905872616772578;0.002086641727724376;0.6529459655301135;[THBS1, MYLK, PDPN, CD36, ANXA1, F2R, TLR4, HBEGF]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, GPR15, FZD5, OR2J2, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, F2R, NPY1R, DGKZ, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0031394;positive regulation of prostaglandin biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.59462270081644;954.1434290848206;8.390779266560578;0.03193432189813256;0.8443458537639685;[ANXA1, AVPR1A, PTGS2]
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;6.0;0.6997970393407541;0.6730188322605215;8.578702127993445;26.976932752798508;4.347727998726029;9.028936615729279E-4;0.5454633246350222;[CHRM2, CHRM1, GRIK3, GRM5, RGS1, PRKACB, PTGDR, LHCGR, PTGIR, GPR37, ANXA1, GLP2R, NPY1R, MC3R, ADCY9, CALCA, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, PLN, CNR1, HRH4, PSAP, FLNA, CCL2, S1PR3, DRD4, CCR1, ABCA1, GABBR1, HTR1E, TSHR, MARCO, RAMP1, LGR4]
GO:0031274;positive regulation of pseudopodium assembly;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;200.71212349518538;7.212124270218933;0.006717654144200148;0.7650689957573628;[CCL21, KIT, CCR7]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, TGFB1, CCL21, FPR2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0002052;positive regulation of neuroblast proliferation;8.0;1.0;0.875;9.628524252492122;500.99868276789744;6.781341354126479;0.016767975042699966;0.7217981122146513;[CX3CR1, SMARCD3]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, GM2A, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, ZAP70, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CORO1A, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0061885;positive regulation of mini excitatory postsynaptic potential;9.0;1.0;0.896240625180289;9.628524252492122;500.93526069116905;9.777073627680469;0.01676585236286803;0.896240625180289;[ADRB2]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, CTGF, EDNRB, AKT1, PRKACB, MEN1, GHSR, LHCGR, POR, ADCY9, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, HHEX, TIMP1, ANXA1, ARG1, GLP2R, SIRT1, TGFBR3, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, CALCRL, FPR2, ADRB2, IGLV1-44, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, IGKV3-20, LRP12, ASGR1, ASGR2, CD36, FCER1G, SYK, DNM2, CEACAM1, COLEC12, LRP1, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1B, LILRB1, CD6, CD9, FCGR2B, RAMP1]
GO:2000969;positive regulation of AMPA receptor activity;10.0;1.0;0.9152410118609203;9.628524252492122;1126.3301560195273;8.16763571524637;0.03769725669064368;0.8329342821725234;[ADRB2]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, EPB41L5, PDGFD, FYN, MEF2C, TGFB1, ARG1, CAV1, COL1A1, NOX4, XCL1]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, CCNH, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, MIF, PRKAR1B, FPR1, TGFA, IQGAP3, PRKAR2B, PDGFD, PDGFC, NCKAP1L, ELANE, EGR1, ACE, FZD5, CDC6, AZU1, PTK2, NOX4, CD24, EZH2, CDKN1A, CCR7, MAP4K1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CCL21, CD40LG, PKN1, CCNT2, TNF, IL6R, PDGFRB, MAP2K2, F2R, ADAM9, CALCA, C5AR1, TNFRSF11A, ADRB2, STAP1, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, PTPRC, CSPG4, LAT, LRRK2, ITGB3, CYR61, GHR, GRM5, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, THBS1, CCL5, FYN, CSK, EGF, MAPK14, CD4]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5, PRKCQ]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[BRCA2, CTGF, RUVBL2, PDGFRB, GHSR, ANXA1, DUSP1, TACR3, IL1B, PCNA, ABCB4, PTGS2, RBBP8, TGFB1, COL1A1, GH1, CD4, EZH2]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CCL21, SLC11A1, CCR7, CCL19]
GO:0070234;positive regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.47524002355703;7.138016298065211;0.00520361636495672;0.7802794972956796;[CD274, CCL5]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, MIF, BTC, SFRP2, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0030850;prostate gland development;5.0;1.0;0.7902410118609202;9.628524252492122;53.04415849917153;7.379178354882098;0.0017753402483239472;0.6676125360964777;[ANXA1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, ARHGAP15, CORO1A, SPTA1, MYH14, PTK2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3]
GO:0045629;negative regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2589.4439345822343;8.390779266560578;0.08666635814222527;0.8916598066706847;[ANXA1, BCL6]
GO:0042119;neutrophil activation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;20.951462914457938;3.578594911188161;7.012266086544604E-4;0.5061298227699893;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, GM2A, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, CCL5, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, SYK, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, IL18RAP, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, CXCL6, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0045627;positive regulation of T-helper 1 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2605.164725512912;7.9853141584524145;0.08719251886688177;0.8709243021859774;[ANXA1, CD80, CCL19]
GO:0010560;positive regulation of glycoprotein biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.34084218004034;731.8700557117284;6.832634648514029;0.024495032124383954;0.7244212536750128;[CCL21, PAWR, CCR7, CCL19, RAMP1]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, NTF3, CCR7, EVI5, CCL21, RHOG, TBC1D9, TBCK, EPHA2]
GO:0045986;negative regulation of smooth muscle contraction;8.0;0.7508913569872202;0.7504456784936101;8.98189708756707;66.40311154199819;7.138016298065211;0.002222452384390169;0.7400384854347593;[DOCK5, CALCA, CALCRL, ADRB2, PTGS2]
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway;7.0;0.6467165523344657;0.6742776414244334;8.623002386890024;189.85671913105512;6.166155715036245;0.006354333529362364;0.6662568552797195;[, ADRB2, GNAI2, CCL5, STMN1]
GO:0045987;positive regulation of smooth muscle contraction;8.0;0.7671156992804218;0.7585578496402109;9.081980546124052;66.30038010178355;6.280566066213989;0.002219014055538479;0.6961884407023742;[GHSR, MYOCD, PTAFR, F2R, TACR3, PTGS2, KIT, PROK2]
GO:0002025;norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure;9.0;1.0;0.896240625180289;9.628524252492122;55.18689913553991;8.67846133901236;0.0018470558490818227;0.8400575416471059;[ADRB2]
GO:0003105;negative regulation of glomerular filtration;7.0;1.0;0.8509193652572005;9.628524252492122;60.825230329867445;8.390779266560578;0.0020357657199873334;0.7800242071602487;[F2R]
GO:0097022;lymphocyte migration into lymph node;8.0;1.0;0.875;9.628524252492122;30.235634434558513;9.777073627680469;0.001011959474220325;0.875;[CCR7]
GO:0097026;dendritic cell dendrite assembly;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;9.083926447120524;0.001960192920240494;0.7876727335416686;[CCL21]
GO:0097029;mature conventional dendritic cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;70.62522642078902;8.390779266560578;0.002363762769726602;0.7522251544931926;[PRTN3, CCR7, CCL19]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, PYCARD, TCL1A, AKT1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, P2RY6, PAK1, NR4A3, CCL5, PDGFD, NOX4]
GO:0045070;positive regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.31211810933421;6.221725566191056;0.0028553198171978322;0.6931793347948383;[CCL5, CD28]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[TNF, CCL5, SLPI, LTF]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, BRCA2, ROPN1L, FBXO5, HOXA5, RUNX2, BTK, CFTR, GATA3, CCL19, FZD5, CCL21, NR4A2, SLC26A8, PLP1, SLC26A3]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, TRBC1, C3AR1, AKT1, PRKACB, MEF2C, HHLA2, FPR1, FPR3, FPR2, GATA3, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, VANGL1, COL1A1, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, HLA-DPA1, PTH2R, FOS, SIRT1, LRRC19, PTAFR, KCNA5, PTGS2, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, P2RY14, USP9Y, TMEM64, HLA-DPB1, LGR4, NCF4, F13A1, CXCL13, CTGF, EFEMP1, AP2M1, LAG3, IFNA14, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, TNFRSF17, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, FASLG, TNFSF13B, HHEX, FCGR3A, ITGB6, TNFRSF1B, ITGA7, LCP2, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, CTHRC1, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, TNFSF11, EPHB1, MIF, BTC, SFRP4, SFRP2, BTK, EPHA3, EPHA2, SDC2, TGFA, CD19, TSPAN5, TSPAN2, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, PPBP, PTK2, ID1, CD28, SDC1, CD24, IGHM, NRP1, PTPRR, NRP2, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR2, FCER1G, SYK, GAB1, RGMA, LAT2, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, SORT1, IL18R1, IL17A, CD86, CD80, TRAC, MPL, CELSR1, CCRL2, IL6R, PDGFRB, CD97, THEMIS, GEM, OSCAR, CCNE1, CARD11, PSEN2, KIR2DL1, RASGRP4, CAV2, CRIM1, INHBA, GH1, IL6, IGKV3-20, SIRPB1, GHR, GRM5, NUP62, IRAK3, MMP9, BCL2A1, SAMHD1, EGF, MAPK14, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, EPS8, STMN1, GPR171, HOXB9, PRKCQ, FLRT2, NCKAP1L, PLCG1, IGHA1, HLA-DQA1, FZD5, GP6, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, NFAM1, AES, FCER2, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, CARD9, G0S2, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, TLE4, CLEC4D, ADAM9, CD151, CALCRL, CUL5, IGLV1-44, EIF2B3, BCL6, CSPG4, LAT, PTPN22, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, XCL1, CX3CR1, P2RY6, PLN, P2RY2, POLR2E, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, P2RX5, P2RX1, MNDA, CLEC2D, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, FLT3LG, RUNX2, TLN1, PFN1, APCDD1, CD79B, CD79A, INPP5D, CCR10, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, IL18RAP, ARHGDIA, TSC2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, ADRB2, STAP1, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A3, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, CLEC12B, DLL1, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:0002032;desensitization of G-protein coupled receptor protein signaling pathway by arrestin;9.0;1.0;0.896240625180289;9.628524252492122;416.97188309209935;9.083926447120524;0.013955673676761097;0.8607930461318132;[ADRB2]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, ATP1B1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, PKHD1, CD19, HRH4, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, CD24, GPR18, CXCL9, ATP2A3, FASLG, GRM5, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL23, CCL21, TMEM64, GPR6, P2RX5, CD4, GRINA, F2RL3]
GO:0051873;killing by host of symbiont cells;7.0;0.811012628672052;0.7564256795932265;9.454170865347344;141.48138775290343;7.57984905034425;0.004735254723107338;0.738553198190834;[CTSG, AZU1, ELANE, CAMP, PF4]
GO:0070493;thrombin-activated receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;7.57984905034425;9.028936615729279E-4;0.710754145523778;[F2R, GP1BA, F2RL3]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD80, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[ICAM2, PYCARD, IL18RAP, PRKACB, LAG3, CD180, CLEC4D, BTK, S100A8, CARD11, LY96, KLRK1, CLEC7A, S100A14, MAP2K6, LYN, CAV1, SH2D1A, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, HMGB2, TNFAIP3, PTPN22, CTSS, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, IRAK3, VAV1, MMP12, TLR1, HCK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, LTF, TLR2, COLEC12, UNC93B1, NLRC4, HSPD1, PAK1, CCL5, FYN, CARD9]
GO:2000503;positive regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1000.5321764499969;7.9853141584524145;0.03348691152528284;0.8407982897480031;[CCL7, CCL5, CCL4, XCL1]
GO:0014808;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;16.0;1.0;1.0;9.628524252492122;562.8564541266966;7.8311634786251565;0.01883829898169905;0.9004860644832351;[CCR5]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, GATA3, LY9, KLRK1, SLAMF7, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, DEFA1, BMX, NFKB1, LCN2, KLRD1, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, LMOD1, PYCARD, CCR7, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, JMY]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, F2R, MIF, EPHA3, EPHA2, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[CCL13, ADAMTS12, PYCARD, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, KMO, NFKB1, CHI3L1, XCL1, RBMX, IL17A]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, TCL1A, AKT1, TNFSF11, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CCR7, HLA-DPA1, MME, ARG1, SIRT1, TLR4, TLR2, CCL13, CXCR4, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, NLRP12, ZYX, IL18R1, IL17A, PYCARD, TLE4, KMO, KIF16B, CALCA, CSF2RB, CORO1A, NFKB1, BSPRY, ALAD, CHUK, CHI3L1, XCL1, MCM2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, CD4, KLF5, IMPDH2, PTPN6, RBMX]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CCL5, PDGFD, PDGFC, FYN, PDGFRB, TGFB2, F2R, SIRT1, PTK2, DCN, FGR, GH1, KIT, CD28, PTPN6, TEK]
GO:0034112;positive regulation of homotypic cell-cell adhesion;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;52.782758271627834;7.9853141584524145;0.001766591417952991;0.7314896500084853;[CCL5, PDPN, TNFSF11]
GO:0051928;positive regulation of calcium ion transport;8.0;0.7043150770688792;0.7271575385344395;8.848365694942547;69.31158403183679;5.085725745451326;0.002319796341169766;0.6350842511328143;[CXCL9, MYLK, LGALS3, JPH2, PDGFRB, TRPC3, TRPC1, F2R, ATP1B1, XCL1, KCNE3, CD19, CCL5, CCL4, CCL2, PLCG1, CCR1, WFS1, CAV1, CXCL10, P2RX5, CD4, CXCL11, CXCL12, F2RL3]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, CCL21, FMR1, ARAP1, CCR7]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IFNA2, GHR, CCL5, FYN, IL6R, LYN, GH1, IL6, IFNG, KIT]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[NRP1, ANXA1, PLK2, PTGS2]
GO:0045920;negative regulation of exocytosis;8.0;0.7140352122741334;0.7320176061370667;9.004369943419128;172.2069348332117;6.375876246018314;0.005763611132688151;0.701062607729944;[ANXA1, FMR1, GNAI2, RAB33B, CEACAM1, FCGR2B, IL13RA2, CCR2]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, TGFB1, MYB, F2R, ENG, CTGF]
GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;292.0931097099921;6.139487467954083;0.009776093515261451;0.7620939872166814;[CALCA, F2R, C3AR1, AGTR1, GPR18, GPR157, F2RL3]
GO:0002518;lymphocyte chemotaxis across high endothelial venule;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;95.76437754181396;9.777073627680469;0.003205147533980157;0.875;[CXCL13]
GO:2000510;positive regulation of dendritic cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;509.141903474748;7.697632086000634;0.01704052131133542;0.8088982747154926;[CCL21, CCR7, CCR6]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, CAMP, DEFA4, RNASE6, RNASE3, DEFA1, PPBP, CXCL10, CXCL11, LTF, PF4]
GO:2000529;positive regulation of myeloid dendritic cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;593.8229823097237;9.777073627680469;0.019874720811918947;0.9324289523296623;[CCL21]
GO:0098586;cellular response to virus;6.0;0.7763722522362496;0.7113064387082693;8.999915593069748;28.654098265158677;6.375876246018314;9.59026881920657E-4;0.6491829203200885;[CHUK, FMR1, MAPK14, MMP12, CCL19]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, CCL20, CXCL13, PYCARD, CXCL10, CXCL12, CCL5, XCL1, CCR2]
GO:0002885;positive regulation of hypersensitivity;10.0;0.7980440201809971;0.8142630219514189;9.439282252853593;636.6186907884354;8.16763571524637;0.021307054661064313;0.8329342821725234;[FCER1G, BTK, CCR7]
GO:0099553;trans-synaptic signaling by endocannabinoid, modulating synaptic transmission;9.0;1.0;0.896240625180289;9.628524252492122;101.34340859682928;8.67846133901236;0.0033918726825895485;0.8400575416471059;[GRM5, CNR1, F2R]
GO:0072173;metanephric tubule morphogenesis;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;32.20947323359611;8.16763571524637;0.0010780220824845236;0.7408135829017477;[CXCR2, LGR4]
GO:2000525;positive regulation of T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;265.86994678880865;9.083926447120524;0.008898427851603871;0.8607930461318132;[CCR7]
GO:2000526;positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation;9.0;1.0;0.896240625180289;9.628524252492122;733.9494972534095;9.777073627680469;0.024564629161408138;0.896240625180289;[CCR7]
GO:0071880;adenylate cyclase-activating adrenergic receptor signaling pathway;10.0;0.8259837884571596;0.8282329060895002;9.446202695698167;86.62055693168666;6.641579411751319;0.00289911208706348;0.7548916918429109;[ADCY9, PLN, ADRB2]
GO:0002407;dendritic cell chemotaxis;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;93.27947089202779;6.8867018697843045;0.0031219799446826077;0.7031056191423581;[CCR1, CXCR1, CCL21, CCL5, CXCR2, CXCR4, CCR7, CCR6, CCL19, CCR5, CCR2]
GO:0010820;positive regulation of T cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1408.745447987039;7.379178354882098;0.04714944235553481;0.8098004765652196;[TNFSF14, CCL5, XCL1, CXCL13, CCR2]
GO:0002408;myeloid dendritic cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;125.05555036753341;8.67846133901236;0.004185496728112903;0.8188169164668168;[CCR7, CCL19]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, BTK, AGTR1, GATA3, ADAMTS12, PLA2G7, CD19, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, ANXA1, FCER1G, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QA, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, IL17A, PROS1, TNF, CDH5, IGHG1, GHSR, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, XCL1, CNR1, CCL5, CCL4, MAPK14, CD6, TEK, FCGR2B]
GO:2000522;positive regulation of immunological synapse formation;8.0;1.0;0.875;9.628524252492122;159.40900365360346;9.777073627680469;0.005335275893496953;0.875;[CCR7]
GO:0072610;interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[CCR7, CCL19]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[AQP9, AKT1, CYP1B1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, ANXA1, ARG1, IL1B, PTAFR, PTGS2, GNAI1, P2RY13, TNC, TNF, SLC8A1, CDH1, RUVBL2, BLM, FOXO1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DNM2, COLEC12, P2RY6, CCL5, CCL2, RAD51, KLF5]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[CALCRL, LRP1, TFRC, CXCR1, CXCR2, CD36, AP2M1, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, CD9, RAMP1]
GO:0045948;positive regulation of translational initiation;9.0;0.7586651285174919;0.775573189439035;9.39368466141472;1253.3709905068713;6.409777797693995;0.04194919909160693;0.7240369598395108;[PPP1R15A, TNF, CCL5]
GO:0040015;negative regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.8359341853073;7.379178354882098;0.004880997473362539;0.7004918368257019;[ADRB2]
GO:0034695;response to prostaglandin E;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;134.30653146733928;6.599019797332524;0.004495118740180942;0.6883935445785896;[CCL21, PTGER2, TGFBR3, P2RY6, AKT1, CCR7, CCL19, PTGDR]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, CYP1B1, EPHB1, SOX4, MEF2C, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, CDC6, NOX4, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, FRZB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, HGS, CD274, CUL5, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, IL6, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, IFNG, XCL1, PDE5A, DLL1, THBS1, CCL8, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, NCKAP1L, PLCG1, ELANE, LYN, JUN, CDC6, CDKN1A, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, ITGB3, FASLG, CYR61, TNFSF13B, LBH, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, CTHRC1, KLF5, DNAJA3, PTPN6, TCL1A, EDNRB, SKP2, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, BTC, SFRP2, TGFA, PKHD1, EGR1, EGR3, TNFSF12, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, CAV2, NR4A1, IL6, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, ZAP70, IFNG, NDUFS4, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, CEBPE, ABLIM3, E2F5, E2F7, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, NHLH2, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, FYN, JUN, WFS1, GABRA5, NR4A2, NR4A3]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, MMP9, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, GNAI2, PAK1, CCL5, PDGFD, ELANE, JUN, IL6, NR4A3]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[F2R, PYCARD, IL1B, TLR8, IL17A]
GO:0070100;negative regulation of chemokine-mediated signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;306.6761070193533;8.16763571524637;0.010264173311360264;0.7926932703116032;[CCL5, PADI2]
GO:0019064;fusion of virus membrane with host plasma membrane;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;56.73089801191601;7.8311634786251565;0.0018987321019653565;0.7514054297404357;[CD4, CXCR4, CCR5]
GO:0014839;myoblast migration involved in skeletal muscle regeneration;7.0;1.0;0.8509193652572005;9.628524252492122;22.014357120524497;9.083926447120524;7.368007211888268E-4;0.8154717862087246;[ANXA1]
GO:0051262;protein tetramerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.917261223318797;0.00140677858073304;0.5745892802266999;[CDA, ADSL, NUP54, ACPP, FBP1, NLGN1, HM13, SAMHD1, CD79A, CCL5, VASP, IMPDH2, CD247]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[RUVBL1, SKP2, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, TNFAIP3, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM105A, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:1901098;positive regulation of autophagosome maturation;9.0;1.0;0.896240625180289;9.628524252492122;490.39656958283985;7.8311634786251565;0.01641313185567848;0.7967266896635242;[ADRB2]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL9, TRPC1, F2R, CXCL10, CXCL11, JPH2, CD19, XCL1, PLCG1, F2RL3]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, PHB2, PROK2, TNFSF11, EPHB1, MIF, EPHA3, EPHA2, FPR1, TGFA, FPR2, SLC30A10, IQGAP3, PDGFD, PDGFC, ELANE, CCR1, JUN, FZD5, MARCO, NOX4, CD24, EZH2, NRP1, CCR7, CD36, HAVCR2, MAP4K1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CD40LG, PKN1, TNF, CTGF, PYCARD, PDGFRB, MAP2K2, F2R, ADAM9, C5AR1, TNFRSF11A, ADRB2, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, CSPG4, LRRK2, TREM2, PTPN22, GHR, CHI3L1, XCL1, PDE5A, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0001780;neutrophil homeostasis;6.0;1.0;0.8231203125901445;9.628524252492122;41.67181410794555;8.16763571524637;0.0013947181159950893;0.7408135829017477;[ANXA1, MTHFD1, PDE4B, MPL, JAM3]
GO:0050862;positive regulation of T cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.212124270218933;0.01221922354838398;0.7438283705770736;[TRAT1, LCK, CCR7]
GO:2000547;regulation of dendritic cell dendrite assembly;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;51.76168527241457;8.67846133901236;0.001732417023575362;0.8188169164668168;[CCL21, CCR7, CCL19]
GO:2000548;negative regulation of dendritic cell dendrite assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;9.777073627680469;0.005818533269131697;0.896240625180289;[CCL21]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, CCL21, LILRB1, CCR7, CCL19]
GO:2000549;positive regulation of dendritic cell dendrite assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;9.777073627680469;0.006704083591926775;0.896240625180289;[CCL19]
GO:0035768;endothelial cell chemotaxis to fibroblast growth factor;9.0;1.0;0.896240625180289;9.628524252492122;91.92245058705075;9.777073627680469;0.003076561696314011;0.896240625180289;[CXCL13]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, CD80, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, ELANE, ABCA1, JUN, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, PTGIR, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:2000545;negative regulation of endothelial cell chemotaxis to fibroblast growth factor;11.0;1.0;0.9324289523296623;9.628524252492122;1104.3280194323595;9.777073627680469;0.03696086497970853;0.9324289523296623;[CXCL13]
GO:0070459;prolactin secretion;9.0;1.0;0.896240625180289;9.628524252492122;236.67564318465372;8.390779266560578;0.007921320783140251;0.8253454670833372;[ANXA1]
GO:0002685;regulation of leukocyte migration;7.0;0.5577261244500507;0.6297824274822259;8.169909229792605;50.8327261637902;4.6122876537569555;0.0017013255982186238;0.586791970363642;[ITGA2B, CXCL13, TNF, PYCARD, LGALS3, C3AR1, HOXA7, IL6R, IL1R1, MIF, PADI2, C5AR1, FPR2, PLA2G7, KLRK1, PDGFD, STAP1, NCKAP1L, S100A14, ELANE, LYN, CCR1, TGFB1, TNFSF14, PPBP, BST1, CXCL10, CXCL11, IL6, CXCL12, GPR18, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, RAC2, CCR7, EMILIN1, CCR6, CCR2, ANXA1, IL1B, XCL1, PTAFR, THBS1, CCL8, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, JAM3, MPP1, CCL21, CCL20, MAPK14, PF4]
GO:0010739;positive regulation of protein kinase A signaling;8.0;1.0;0.875;9.628524252492122;237.72454511224748;7.57984905034425;0.007956426586706367;0.7626338329336335;[ADRB2, MIF]
GO:0002676;regulation of chronic inflammatory response;7.0;0.7586651285174919;0.7302519295159464;9.0689084645567;34.07149622250282;7.57984905034425;0.0011403423162113378;0.738553198190834;[CCL5, TNFAIP3, TNF]
GO:0042063;gliogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.9853141584524145;7.282666309192915E-4;0.6986103492792611;[ANXA1]
GO:0002438;acute inflammatory response to antigenic stimulus;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;43.66651068845287;7.57984905034425;0.0014614788154342952;0.710754145523778;[CD6, CXCR2, GATA3, ELANE]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, PYCARD, CD36, CCR2, HAVCR2, FCER1G, MIF, TLR1, TLR4, TLR2, PTAFR, LY96, THBS1, CCL19, FZD5, CARD9, AZU1, CD2, PF4]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, F2R, FASLG, JPH2, PTPRC, LCK, XCL1, CCR7, CCL19, CCR5]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, LCK, S100A8, NLRC4, HSPD1, NLRP3, TNFRSF10B, HSPE1, NLRP12, P2RX1]
GO:0071731;response to nitric oxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;66.42530163189308;6.832634648514029;0.0022231950667291668;0.639662265535933;[FOXO1, DNM2, CCR7, CCL19]
GO:0060155;platelet dense granule organization;6.0;1.0;0.8231203125901445;9.628524252492122;22.861654980906852;7.697632086000634;7.651590180572567E-4;0.7167775754447168;[ABCA1, F2R, F2RL3]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, CCL1, FPR2, S100A14, PLA2G7, CCR2]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0043950;positive regulation of cAMP-mediated signaling;8.0;0.8436909121759173;0.7968454560879586;9.517298617381897;239.5163045814748;6.686031174322154;0.008016395163662574;0.7169239451870815;[CXCL10, CXCL9, CXCL11, PF4]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, RNASE6, RNASE3, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A14, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, IGKC, CCL20, CARD9, CD4]
GO:0045217;cell-cell junction maintenance;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;51.610367046990525;7.474488534686424;0.0017273525387479806;0.6724867031240476;[F2R, PRTN3, CD177]
GO:0046427;positive regulation of JAK-STAT cascade;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;286.6013214379199;5.459585514144159;0.009592288304083759;0.675444082270312;[IFNA2, PRL, GHR, CCL5, CYP1B1, FYN, IL6R, LYN, F2R, GH1, IL6, IFNG, KIT]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[DSP, YAP1, ST14, JAG1, ANXA1, ADAM9, EPHA2]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, PNOC, PROK2, GPR19]
GO:0050482;arachidonic acid secretion;12.0;1.0;0.9481203125901445;9.628524252492122;224.85573033724626;6.599019797332524;0.007525718937368459;0.7855944919115336;[ACE, ANXA1, PNPLA8, DRD4]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, LYN, TGFB1, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0010744;positive regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;113.85781812010546;7.004484905440688;0.0038107187070962377;0.6813299963962409;[MSR1, AGTR1, CD36, NFKB1, PF4]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, KLRK1, STAP1, TGFB1, JAG1, JUP, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TMEFF2, ENG, CX3CR1, LRP1, THBS1, CCL2, CCL21, TIE1, PODN]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, PPBP, PTK2, COL1A1, NOX4, NRP1, NRP2, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, SIRT1, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, IL6R, PDGFRB, F2R, ADAM9, CD274, CD151, C5AR1, CORO1A, TGFB2, TGFB1, CXCL10, CXCL11, IL6, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0045907;positive regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.57973408832269;103.52331479149503;6.280566066213989;0.003464832181136806;0.6961884407023742;[CAV1, PTAFR, F2R, AVPR1A, PTGS2, AKT1]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[PF4]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, TNF, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, GATA3, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, IL6, CXCL12, PTPRC, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, CHUK, IRAK3, MMP12, ACTA2, EEF1G, FGR, IFNG, PSMA2, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, CCT5, CARD9, LILRB1, MAPK14]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[BLM, MCM7, RAD54B, RUVBL2, RUVBL1, ANXA1, HMGA1, RPA1, RAD50, RAD51, MCM4, MCM6, MCM2]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, FOXO1, IL18RAP, PDGFD, MYB, CYP1B1, ANXA1, ARG1, SIRT1, PAX2, IL6, EZH2]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, ANTXR1, PAK1, FLNA, CXADR, ANXA1, GAB1, KIT]
GO:0032743;positive regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.409777797693995;0.002183412136085803;0.6509166472493662;[CD86, CD83, CD80, CD3E, PDE4B, CCR2, ANXA1, CD4, IL1B, CD28, PRKCQ, CARD11]
GO:0033030;negative regulation of neutrophil apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.083926447120524;0.010085298248760914;0.8607930461318132;[CXCR2]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6]
GO:0050706;regulation of interleukin-1 beta secretion;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;155.12756668048587;6.166155715036245;0.005191980051049822;0.7305785018834392;[ORM1, PYCARD, NLRP3, CCR7, CCL19, FZD5, NLRP12, TLR8, TLR4]
GO:0033031;positive regulation of neutrophil apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;300.80443177442305;8.390779266560578;0.010067653625077092;0.8253454670833372;[ANXA1]
GO:0045918;negative regulation of cytolysis;5.0;0.8259837884571596;0.7032329060895001;9.377209824211215;41.247147119458;8.390779266560578;0.0013805048940658876;0.7193458537639684;[PAX2, PF4]
GO:1903237;negative regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;459.0491676986248;8.390779266560578;0.015363962525443897;0.8443458537639685;[CXCL12, CCL21]
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.976932752798508;5.288437257948329;9.028936615729279E-4;0.5935712398991049;[CHRM2, LHCGR, CHRM1, C5AR1, F2R, FPR1, FPR3, FPR2, GPR84, NMBR, MC3R, GRM5, P2RY6, EDNRB, P2RY2, CXCR2, C3AR1, AGTR1, F2RL3]
GO:0007205;protein kinase C-activating G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.444869117505266;9.028936615729279E-4;0.6527112189764278;[CHRM1, LRP1, F2R, AZU1, DGKZ]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CD24, GPR18, CXCL9, FASLG, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL21, GPR6, P2RX5, CD4, F2RL3]
GO:0031649;heat generation;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;21.014590666490108;7.697632086000634;7.033394377036888E-4;0.7167775754447168;[IL1B, ADRB2]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[HSPD1, CCR7, CD36, CCL19, MAPK14, CD40LG, IFNG, TLR4, TLR2]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL21, CCL20, TNFRSF11A, LGALS3, IL6, CCL8, CCL7, CCL5, CCL4, TNFSF11, CCL2, XCL1, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[F2R, FLT3LG, CORO1A, CCR2]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR2, CCR1, CCL23, CCL21, CCL20, PPBP, CXCL10, CXCL11, CXCL12, XCL1, PF4]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[PHB2, AKT1, PROK2, MEF2C, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, SFN, NCKAP1L, BARD1, JUN, PLK2, AZU1, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLEC5A, F2R, MSH2, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, CX3CR1, LRP1, NLRC4, CCL5, CCL2, FYN, TIE1, IL2RB, SLC46A2, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, CTSH, CCR7, CCR5, FCER1G, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, CXCR2, PDPN, LILRB1, CD40LG, GRINA, COMP, ARHGDIA, PDGFRB, GHSR, C5AR1, PSEN2, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, HSPD1, TEK]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, CCL21, CARD9, CD40LG, PKN1, LTBR, FCGR2B]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ITGB3, NCF4, CD36, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, ELANE, MARCO]
GO:0071621;granulocyte chemotaxis;8.0;0.8653626801206646;0.8076813400603323;9.434368238051164;96.32399332974941;5.311165509025885;0.0032238773707808457;0.6466132511260384;[CXCL6, CCL13, CXCL9, CSF3R, C5AR1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, ANXA1, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL1, S100A8, PF4]
